Cross-talk between endocrine-disrupting chemicals and cytokine signaling through estrogen receptors.
D045744:Cell Line, Tumor; D016207:Cytokines / Q000378:metabolism / Q000502:physiology*; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D004703:Endocrine System / Q000187:drug effects*; D004726:Endosulfan / Q000378:metabolism; D020847:Estrogen Receptor Modulators / Q000494:pharmacology; D006801:Humans; D015850:Interleukin-6 / Q000494:pharmacology; D053605:Leukemia Inhibitory Factor; D008156:Luciferases / Q000378:metabolism; D020935:MAP Kinase Signaling System / Q000187:drug effects / Q000502:physiology; D008731:Methoxychlor / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism; D010636:Phenols / Q000378:metabolism; D010766:Phosphorylation; D020239:Receptor Cross-Talk / Q000187:drug effects / Q000502:physiology*; D011960:Receptors, Estrogen / Q000187:drug effects / Q000378:metabolism*; D050796:STAT3 Transcription Factor; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D013629:Tamoxifen / Q000494:pharmacology; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D014158:Transcription, Genetic / Q000187:drug effects / Q000502:physiology; D014162:Transfection
D016207:Cytokines; D004268:DNA-Binding Proteins; D020847:Estrogen Receptor Modulators; D015850:Interleukin-6; C507837:LIF protein, human; D053605:Leukemia Inhibitory Factor; D016328:NF-kappa B; D010636:Phenols; D011960:Receptors, Estrogen; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; D015534:Trans-Activators; D013629:Tamoxifen; D008156:Luciferases; D004726:Endosulfan; D008731:Methoxychlor